CNC
ELV icon

Canandaigua National Corp’s Elevance Health ELV Stock Holding History

Canandaigua National Corp’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$486K Buy
+1,661
New +$546K 0.04% 237

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Canandaigua National Corp's ELV Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in Elevance Health (ELV) in Q1 2026: 1,661 shares worth $486K. The stake represents 0.04% of the portfolio and ranks #237 among its holdings.

1,466 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Canandaigua National Corp held 1,661 shares of Elevance Health worth $486K as of Q1 2026.
  • Elevance Health was a new Canandaigua National Corp position in Q1 2026.
  • Elevance Health made up 0.04% of Canandaigua National Corp's portfolio in Q1 2026, its #237 holding.
  • 1,466 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.